| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An evaluation of thymidine phosphorylase as a means of preventing thymidine rescue from the thymidylate synthase inhibitor raltitrexed
|
Graham-Cole, Claire L.
|
|
2006
|
59 |
2 |
p. 197-206
|
article
|
| 2 |
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies
|
Ma, Cynthia
|
|
2006
|
59 |
2 |
p. 207-215
|
article
|
| 3 |
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma
|
Mita, Monica M.
|
|
2006
|
59 |
2 |
p. 165-174
|
article
|
| 4 |
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-α2b in patients with solid tumors
|
Schneider, Bryan
|
|
2006
|
59 |
2 |
p. 261-268
|
article
|
| 5 |
Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model
|
Abramjuk, Claudia
|
|
2006
|
59 |
2 |
p. 275-282
|
article
|
| 6 |
5-Fluorouracil prevents lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells by inhibiting Akt-dependent nuclear factor-κB activation
|
Islam, Shamima
|
|
2006
|
59 |
2 |
p. 227-233
|
article
|
| 7 |
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells
|
Müller, Christine
|
|
2006
|
59 |
2 |
p. 157-164
|
article
|
| 8 |
In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin)
|
Ryu, Jung Su
|
|
2006
|
59 |
2 |
p. 283-284
|
article
|
| 9 |
Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells
|
Liu, Jingbo
|
|
2006
|
59 |
2 |
p. 217-225
|
article
|
| 10 |
Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity
|
Henley, D.
|
|
2006
|
59 |
2 |
p. 235-249
|
article
|
| 11 |
Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting
|
Lu, Hongxia
|
|
2006
|
59 |
2 |
p. 175-181
|
article
|
| 12 |
Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan
|
Sugarbaker, Paul H.
|
|
2006
|
59 |
2 |
p. 151-155
|
article
|
| 13 |
Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer
|
Seo, Jae Hong
|
|
2006
|
59 |
2 |
p. 269-274
|
article
|
| 14 |
Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas
|
Losa, R.
|
|
2006
|
59 |
2 |
p. 251-259
|
article
|
| 15 |
Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma
|
Carter, Christopher A.
|
|
2006
|
59 |
2 |
p. 183-195
|
article
|
Journal description